Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Amelioration of Cisplatin-Induced Nephrotoxicity in Rats by Curcumin and α-Tocopherol

Sarawoot Palipoch1 , Chuchard Punsawad1, Dutsadee Chinnapun1, Prasit Suwannalert2

1School of Medicine, Walailak University, Nakhon Si Thammarat, 80161; 2Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.

For correspondence:-  Sarawoot Palipoch   Email: spalipoch@hotmail.com   Tel:+6675672873

Received: 11 October 2013        Accepted: 20 November 2013        Published: 24 December 2013

Citation: Palipoch S, Punsawad C, Chinnapun D, Suwannalert P. Amelioration of Cisplatin-Induced Nephrotoxicity in Rats by Curcumin and α-Tocopherol. Trop J Pharm Res 2013; 12(6):973-979 doi: 10.4314/tjpr.v12i6.16

© 2013 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the possible protective role of curcumin and α-tocopherol against cisplatin-induced nephrotoxicity in rat.
Methods: Male Wistar rats were divided into five groups. Groups 1 and 2 were intraperitoneally (i.p.) injected with normal saline and cisplatin (20 mg/kg), respectively. Groups 3, 4 and 5 were pre-treated with a single doses of α-tocopherol (250 mg/kg), curcumin (200 mg/kg) and α-tocopherol with curcumin, respectively, for 24 h prior to the administration of cisplatin. After 72 h following injection, specimens were collected. Serum blood urea nitrogen (BUN), creatinine and malondialdehyde (MDA) levels, superoxide dismutase (SOD) and catalase activities, kidney histopathological study and gene expressions of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and p38 mitogen-activated protein kinase (p38-MAPK) were investigated.
Results: Pre-treatment with combined curcumin and α-tocopherol exhibited significantly reduced MDA levels and enhanced activities of SOD and catalase compared with cisplatin-treated group (p < 0.05). It also improved BUN as well as creatinine levels and kidney histopathology. Moreover, gene expressions of NADPH oxidase were decreased, whereas p38-MAPK gene expressions were not significant compared with cisplatin-treated group.
Conclusion: Combined curcumin and α-tocopherol are able to reduce cisplatin-induced nephrotoxicity via possible inhibition of NADPH oxidase, resulting in improvement of kidney function and histology.

Keywords: Cisplatin, Oxidative stress, Curcumin, ^5;-Tocopherol, Nephrotoxicity

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates